Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital

Neville, Heather L., Chevalier, Bernadette, Daley, Chris, Nodwell, Lisa, Harding, Claudia, Hiltz, Anne, MacDonald, Tammy, Skedgel, Chris, MacKinnon, Neil J. and Slayter, Kathryn (2014) Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital. International Journal of Pharmacy Practice, 22 3: 216-222. doi:10.1111/ijpp.12058

Author Neville, Heather L.
Chevalier, Bernadette
Daley, Chris
Nodwell, Lisa
Harding, Claudia
Hiltz, Anne
MacDonald, Tammy
Skedgel, Chris
MacKinnon, Neil J.
Slayter, Kathryn
Title Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital
Journal name International Journal of Pharmacy Practice   Check publisher's open access policy
ISSN 0961-7671
Publication date 2014-06
Sub-type Article (original research)
DOI 10.1111/ijpp.12058
Open Access Status
Volume 22
Issue 3
Start page 216
End page 222
Total pages 7
Place of publication Chichester, West Sussex, United Kingdom
Publisher John Wiley & Sons
Collection year 2015
Language eng
Formatted abstract
Objective: Clinical pharmacists improve the quality of patient care by reducing adverse drug events (ADEs), length of stay and mortality. This impact is currently not well described in surgery. The objective was to evaluate clinical and economic outcomes after clinical pharmacist services were added to two general surgical wards in an adult hospital.

Methods: This was a prospective, observational study. All clinical interventions to resolve drug therapy problems were documented and assessed for severity, value and the probability of preventing an ADE. Cost avoidance was calculated using two methods: by avoiding additional days in hospital (CA$3593/ADE) or additional hospital costs ($7215/ADE). Two clinical pharmacy specialists and the surgical care pharmacist independently categorized the interventions; disagreements were resolved by consensus.

Key findings: The pharmacists made 1097 interventions in 6 months with a 98% acceptance rate by surgical staff. Half of the interventions were rated significant for severity (561, 51.1%) and value (559, 51.0%). One-quarter of the interventions had a 40% or greater probability of preventing an ADE (270, 24.6%). Cost avoidance was estimated to be $0.68-1.36 million or $617-1239 per intervention. Pharmacists avoided an additional 867 days in the hospital for surgical patients.

Conclusion: The pharmacist's role in the management of the drug therapy needs of the post-surgical patient has the potential to improve clinical and patient outcomes and avoid healthcare costs. The inclusion of clinical pharmacists in surgical wards may result in $7 in savings for every $1 invested.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Non HERDC
School of Pharmacy Publications
Version Filter Type
Citation counts: Scopus Citation Count Cited 3 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 30 Jul 2014, 14:39:28 EST by Bernadette Chevalier on behalf of School of Pharmacy